Clinical Trials Browser

Phase 2 × ruxolitinib × Head & Neck × Clear all

NCT03153982 2024-10-30

Ruxolitinib in Operable Head and Neck Cancer

Phase 2 Terminated

16 enrolled 9 charts

Squamous Cell Carcinoma of Head and Neck